Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.

Cancer research - 15 Apr 1991

McLaughlin K, Stephens I, McMahon N, Brown R

Abstract excerpt

We have shown that cis diamminedichloroplatinum-(II) (DDP) resistant mutants can be isolated from the human ovarian carcinoma cell line A2780 using a single-step selection protocol with DDP. DDP resistant colonies were calculated to be present at a frequency of 1.7 x 10(-6)/viable cell using a fluctuation analysis. The mutational origin of these surviving colonies is inferred by the fact that their frequency is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Survival
Share to Cisplatin
Share to Diterpenes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Mutation

Share to Ovarian Neoplasms

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 1901242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.PMID 1901242Read ↗

Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma.Semantic proximity Read ↗

Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.Semantic proximity Read ↗

Increased accumulation of p53 protein in cisplatin‐resistant ovarian cell linesSemantic proximity Read ↗

Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.Semantic proximity Read ↗

cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell linesSemantic proximity Read ↗

Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.Semantic proximity Read ↗

Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli.Semantic proximity Read ↗

Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis.Semantic proximity Read ↗

Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe.Semantic proximity Read ↗

Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II).Semantic proximity Read ↗

Effect of chemotherapy on the mutation frequency of ovarian cancer cells at the HPRT locus.Semantic proximity Read ↗

Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.